🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of Bortezomib wh...
Status
Completed
Location
H. Lee Moffitt Cancer Center
Start Date
2009-06-18
Trial ID
NCT00948922
Treatments Being Tested
The hypothesis for this study is that the regimen consisting of fludarabine...
Status
Completed
Location
John Theurer Cancer Center at Hackensack University Medical Center
Start Date
2010-06-09
Trial ID
NCT01453101
Treatments Being Tested
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
City of Hope
Start Date
2011-01-28
Trial ID
NCT01163357
The primary objective of this study is to analyze the efficacy of allogenei...
Status
Completed
Location
H. Clinic I Provincial
Start Date
2007-11
Trial ID
NCT00564200
Treatments Being Tested
This study is designed to compare progression-free survival (PFS) from rand...
Status
Completed
Location
University of Alabama
Start Date
2015-08
Trial ID
NCT02440464
Treatments Being Tested
The clinical trial was conducted in a cohort of young, high-risk myeloma pa...
Status
Unknown
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2018-01-05
Trial ID
NCT04008888
This phase II trial studies the side-effects and anti-cancer effects of giv...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2008-10
Trial ID
NCT00793572
Treatments Being Tested